Home > Insider Trading > Filing (0000950170-23-066217)

Filing Details

Accession Number:: 0000950170-23-066217
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-11-27 20:48:47
Reporting Period:: 2023-11-22

Accepted Time:: 2023-11-27 20:48:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1703647	Korro Bio Inc.	KRRO	Pharmaceutical Preparations (2834)	472324450

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1785288	L. David Lucchino	C/O Korro Bio, Inc. One Kendall Square, Building 600-700 Cambridge MA 02139		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-11-22	110	$35.99	23,196	No	4	S	Direct
Common Stock	Disposition	2023-11-22	230	$36.74	22,966	No	4	S	Direct
Common Stock	Disposition	2023-11-22	614	$37.98	22,352	No	4	S	Direct
Common Stock	Disposition	2023-11-22	202	$38.82	22,150	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance restricted stock units, and does not represent a discretionary trade by the Reporting Person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.26 to $36.06, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.40 to $37.20, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.52 to $38.35, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.62 to $39.015, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.